CHO Pharma, Inc. (TPEX: 6586)
60.50
-1.20 (-1.94%)
Sep 10, 2024, 3:00 PM CST
CHO Pharma Company Description
CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs.
It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia.
The company was founded in 2012 and is based in Taipei City, Taiwan.
CHO Pharma, Inc.
Country | Taiwan |
Founded | 2012 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Chung-Yi Wu |
Contact Details
Address: Building C Taipei, 115202 Taiwan | |
Phone | 886 2 2655 8059 |
Website | chopharma.com |
Stock Details
Ticker Symbol | 6586 |
Exchange | Taipei Exchange |
Fiscal Year | January - December |
Reporting Currency | TWD |
SIC Code | 2834 |
Key Executives
Name | Position |
---|---|
Dr. Chung-Yi Wu Ph.D. | President, Chief Executive Officer, GM and Director |
Sammi Chou | Chief Financial Officer |
Dr. Ling-Mei Wang | Vice President of Operation |
Yibei Zhou | Accounting Supervisor |